Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-13

Clinical Trial Update: Reletex for Nausea in GERD Patients [NA]

View source ↗

Summary

The clinical trial evaluating Reletex for nausea in patients with gastroesophageal reflux disease was terminated, and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Reletex

Snippet

Sponsor: Northwestern University | Conditions: Nausea | NA | Status: TERMINATED | Results posted: 2014-11-13